Ming‐Chin Yu

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

Apinya Jusakul, Ioana Cutcutache, Chern Han Yong et al. · Cancer Discovery · 2017 · 989 citations · Full text

Medicine, Genetics, Oncology +17

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia

Alvin Wei Tian Ng, Song Ling Poon, Mi Ni Huang et al. · Science Translational Medicine · 2017 · 378 citations

Medicine, Oncology, Toxicology +10

Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China

Fu-Sun Yeh, Ming‐Chin Yu, Chanyin Mo et al. · Health Policy · 1990 · 325 citations

Medicine, Infectious Diseases, Oncology +16

MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma

Tsung‐Chieh Shih, Yin-Jing Tien, Chih-Jen Wen et al. · Journal of Hepatology · 2012 · 185 citations

Medicine, Molecular Biology, Oncology +14